collection
MENU ▼
Read by QxMD icon Read
search

Thank You for (Not) Smoking

shared collection
55 papers 0 to 25 followers Increasing tobacco cessation rates
By Edwin Kim Resident Physician, Aspiring Addiction Psychiatrist
https://www.readbyqxmd.com/read/19558259/worsening-psychosis-induced-by-varenicline-in-a-hospitalized-psychiatric-patient
#1
Bethany A DiPaula, Michele D Thomas
Varenicline is a novel treatment for smoking cessation; however, the agent has not been well studied in a population with severe mental illness. Varenicline can reportedly cause neuropsychiatric adverse effects, some resulting in hospitalizations and/or suicides. We describe a case of clinician-observed, worsening psychotic symptoms in a patient with chronic mental illness who was receiving varenicline. A 45-year-old woman with bipolar disorder, mixed type with psychotic features, was admitted to a psychiatric hospital due to acute decompensation after she discontinued her drug therapy...
July 2009: Pharmacotherapy
https://www.readbyqxmd.com/read/18984856/varenicline-associated-acute-renal-failure
#2
Matthew L Bird, Kimi S Vesta
OBJECTIVE: To report an association between acute renal failure and varenicline. CASE SUMMARY: A 53-year-old white male with preexisting moderate renal insufficiency was admitted to the hospital for acute renal failure following a change in serum creatinine from 4 mg/dL at baseline to 10.6 mg/dL upon admission. One week prior to admission, the patient started taking varenicline (dose undetermined) for smoking cessation and had been stable on all other medications for 2 months prior to admission...
December 2008: Annals of Pharmacotherapy
https://www.readbyqxmd.com/read/26553744/varenicline-for-smoking-cessation-in-hospitalized-patients-with-acute-coronary-syndrome
#3
RANDOMIZED CONTROLLED TRIAL
Mark J Eisenberg, Sarah B Windle, Nathalie Roy, Wayne Old, François R Grondin, Iqbal Bata, Ayman Iskander, Claude Lauzon, Nalin Srivastava, Adam Clarke, Daniel Cassavar, Danielle Dion, Herbert Haught, Shamir R Mehta, Jean-François Baril, Charles Lambert, Mina Madan, Beth L Abramson, Payam Dehghani
BACKGROUND: Less than one-third of smokers hospitalized with an acute coronary syndrome (ACS) remain abstinent following discharge. We assessed whether varenicline, begun in-hospital, is efficacious for smoking cessation following ACS. METHODS AND RESULTS: We conducted a multi-center, double-blind, randomized, placebo-controlled trial in which smokers hospitalized with an ACS were randomized to varenicline or placebo for 12 weeks. All patients received low-intensity counseling...
January 5, 2016: Circulation
https://www.readbyqxmd.com/read/24934962/combination-treatment-with-varenicline-and-bupropion-in-an-adaptive-smoking-cessation-paradigm
#4
RANDOMIZED CONTROLLED TRIAL
Jed E Rose, Frédérique M Behm
OBJECTIVE: The authors assessed the efficacy and safety of combination treatment with varenicline and sustained-release bupropion for smokers who, based on an assessment of initial smoking reduction prior to the quit date, were deemed unlikely to achieve abstinence using nicotine patch treatment. METHOD: In a randomized, double-blind, parallel-group adaptive treatment trial, the authors identified 222 cigarette smokers who failed to show a reduction of more than 50% in smoking after 1 week of nicotine patch treatment...
November 1, 2014: American Journal of Psychiatry
https://www.readbyqxmd.com/read/27116918/neuropsychiatric-safety-and-efficacy-of-varenicline-bupropion-and-nicotine-patch-in-smokers-with-and-without-psychiatric-disorders-eagles-a-double-blind-randomised-placebo-controlled-clinical-trial
#5
RANDOMIZED CONTROLLED TRIAL
Robert M Anthenelli, Neal L Benowitz, Robert West, Lisa St Aubin, Thomas McRae, David Lawrence, John Ascher, Cristina Russ, Alok Krishen, A Eden Evins
BACKGROUND: Substantial concerns have been raised about the neuropsychiatric safety of the smoking cessation medications varenicline and bupropion. Their efficacy relative to nicotine patch largely relies on indirect comparisons, and there is limited information on safety and efficacy in smokers with psychiatric disorders. We compared the relative neuropsychiatric safety risk and efficacy of varenicline and bupropion with nicotine patch and placebo in smokers with and without psychiatric disorders...
June 18, 2016: Lancet
https://www.readbyqxmd.com/read/28034998/the-methodological-quality-and-effectiveness-of-technology-based-smoking-cessation-interventions-for-disadvantaged-groups-a-systematic-review-and-meta-analysis
#6
REVIEW
Veronica C Boland, Emily A Stockings, Richard P Mattick, Hayden McRobbie, Jamie Brown, Ryan J Courtney
AIMS: To assess the methodological quality and effectiveness of technology-based smoking cessation interventions in disadvantaged groups. METHOD: Four databases (EMBASE, Cochrane, Medline, and PsycInfo) were searched for studies conducted from 1980- May 2016. Randomised controlled trials that compared a behavioural smoking cessation intervention delivered primarily through a technology-based platform (e.g. mobile phone) with a no-intervention comparison group among disadvantaged smokers were included...
December 29, 2016: Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco
https://www.readbyqxmd.com/read/28013270/impact-of-the-2015-cms-inpatient-psychiatric-facility-quality-reporting-ipfqr-rule-on-tobacco-treatment
#7
Shane Carrillo, Niaman Nazir, Eric Howser, Lisa Shenkman, Melinda Laxson, Taenisha S Scheuermann, Kimber P Richter
INTRODUCTION: In its fiscal year (FY) 2015 final rule, the Centers for Medicare & Medicaid (CMS) required reporting of tobacco treatment quality measures as part of the Inpatient Psychiatric Facilities Prospective Payment System (IPF PPS). This pre-intervention, post-intervention policy analysis evaluates the impact of that policy at a large academic medical center that opted to improve performance as it implemented reporting measures. METHODS: Electronic medical record data were collected retrospectively for all adult (≥18 years) inpatient psychiatric admissions from January 1(st) 2014 to December 31(st) 2015...
December 24, 2016: Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco
https://www.readbyqxmd.com/read/25506771/proactive-tobacco-cessation-outreach-to-smokers-of-low-socioeconomic-status-a-randomized-clinical-trial
#8
RANDOMIZED CONTROLLED TRIAL
Jennifer S Haas, Jeffrey A Linder, Elyse R Park, Irina Gonzalez, Nancy A Rigotti, Elissa V Klinger, Emily Z Kontos, Alan M Zaslavsky, Phyllis Brawarsky, Lucas X Marinacci, Stella St Hubert, Eric W Fleegler, David R Williams
IMPORTANCE: Widening socioeconomic disparities in mortality in the United States are largely explained by slower declines in tobacco use among smokers of low socioeconomic status (SES) than among those of higher SES, which points to the need for targeted tobacco cessation interventions. Documentation of smoking status in electronic health records (EHRs) provides the tools for health systems to proactively offer tobacco treatment to socioeconomically disadvantaged smokers. OBJECTIVE: To evaluate a proactive tobacco cessation strategy that addresses sociocontextual mediators of tobacco use for low-SES smokers...
February 2015: JAMA Internal Medicine
https://www.readbyqxmd.com/read/11586190/smoking-and-erectile-dysfunction-evidence-based-analysis
#9
REVIEW
K T McVary, S Carrier, H Wessells
PURPOSE: We examined available evidence concerning the role of smoking in the development of erectile dysfunction. This task involved a complete review of the smoking literature as it pertained to erectile dysfunction and select endothelial diseases. MATERIALS AND METHODS: We comprehensively reviewed the literature, including PubMed and recent abstract proceedings from national meetings relevant to smoking, erectile dysfunction and endothelial diseases. The quality of the evidence was assessed by methods used to develop clinical practice guidelines...
November 2001: Journal of Urology
https://www.readbyqxmd.com/read/21933940/smoke-free-policies-in-psychiatric-services-identification-of-unmet-needs
#10
Montse Ballbè, Gemma Nieva, Sílvia Mondon, Cristina Pinet, Eugeni Bruguera, Esteve Saltó, Esteve Fernández, Antoni Gual
INTRODUCTION: Smoke-free policies have been extended to enclosed workplaces in many countries; however, smoking continues to be commonly allowed on psychiatric premises. The aim of this study was to describe tobacco control strategies undertaken in psychiatric inpatient services and day centres in Spain. METHODS: This cross-sectional survey included all psychiatric service centres that offered public services in Catalonia, Spain (n=192). Managers responded to a questionnaire of 24 items that covered four dimensions, including clinical intervention, staff training and commitment, smoking area management and communication of smoke-free policies...
November 2012: Tobacco Control
https://www.readbyqxmd.com/read/25510845/do-people-with-mental-illness-receive-adequate-smoking-cessation-advice-a-systematic-review-and-meta-analysis
#11
REVIEW
Alex J Mitchell, Davy Vancampfort, Marc De Hert, Brendon Stubbs
BACKGROUND: Prevalence rates of smoking in people with mental illness are high, and premature mortality attributed to tobacco related physical comorbidity is a major concern. We conducted a meta-analysis comparing rates of receipt of smoking cessation advice among people with and without mental illness. METHOD: Major electronic databases were searched from inception till August 2014 for studies comparing rates of receipt of smoking cessation advice of people with and without a mental illness...
January 2015: General Hospital Psychiatry
https://www.readbyqxmd.com/read/26339210/smoking-use-and-cessation-among-people-with-serious-mental-illness
#12
REVIEW
Aniyizhai Annamalai, Noreen Singh, Stephanie S O'Malley
Smoking rates in people with serious mental illness (SMI) are disproportionately high compared to the general population. It is a leading contributor to the early mortality in this population. Smoking cessation rates are low in this group, though patients are motivated to quit. Unfortunately, health care providers do not always prioritize smoking cessation for this population. This review provides an overview of prevalence rates, biological effects that maintain smoking, and evidence-based treatments for smoking cessation in SMI...
September 2015: Yale Journal of Biology and Medicine
https://www.readbyqxmd.com/read/26594837/efficacy-and-tolerability-of-pharmacotherapy-for-smoking-cessation-in-adults-with-serious-mental-illness-a-systematic-review-and-network-meta-analysis
#13
REVIEW
Emmert Roberts, A Eden Evins, Ann McNeill, Debbie Robson
BACKGROUND AND AIMS: To assess the efficacy and tolerability of adjunctive pharmacotherapy for smoking cessation in adults with serious mental illness (SMI) by means of a systematic review and network meta-analysis. METHOD: We searched Embase, Medline, PsychINFO and the Cochrane Central Register of Controlled Trials from database inception to 1 December 2014 for randomized controlled trials (RCTs) published in English. We included all studies of smokers with SMI (including schizophrenia, schizoaffective disorder, bipolar disorder, delusional disorder and depressive psychoses) who were motivated to quit smoking...
April 2016: Addiction
https://www.readbyqxmd.com/read/24467257/multiple-risk-behavior-profiles-of-smokers-with-serious-mental-illness-and-motivation-for-change
#14
RANDOMIZED CONTROLLED TRIAL
Judith J Prochaska, Sebastien C Fromont, Kevin Delucchi, Kelly C Young-Wolff, Neal L Benowitz, Stephen Hall, Thomas Bonas, Sharon M Hall
OBJECTIVE: Individuals with serious mental illness (SMI) are dying on average 25 years prematurely. The leading causes are chronic preventable diseases. In the context of a tobacco-treatment trial, this exploratory study examined the behavioral risk profiles of adults with SMI to identify broader interventional needs. METHOD: Recruited from five acute inpatient psychiatry units, participants were 693 adult smokers (recruitment rate = 76%, 50% male, 45% Caucasian, age M = 39, 49% had income < $10,000) diagnosed with mood disorders (71%), substance-use disorders (63%), posttraumatic stress disorder (39%), psychotic disorders (25%), and attention deficit-hyperactivity disorder (25%)...
December 2014: Health Psychology: Official Journal of the Division of Health Psychology, American Psychological Association
https://www.readbyqxmd.com/read/26221050/interventions-to-address-medical-conditions-and-health-risk-behaviors-among-persons-with-serious-mental-illness-a-comprehensive-review
#15
REVIEW
Emma E McGinty, Julia Baller, Susan T Azrin, Denise Juliano-Bult, Gail L Daumit
People with serious mental illness (SMI) have mortality rates 2 to 3 times higher than the overall US population, largely due to cardiovascular disease. The prevalence of cardiovascular risk factors such as obesity and diabetes mellitus and other conditions, such as HIV/AIDS, is heightened in this group. Based on the recommendations of a National Institute of Mental Health stakeholder meeting, we conducted a comprehensive review examining the strength of the evidence surrounding interventions to address major medical conditions and health-risk behaviors among persons with SMI...
January 2016: Schizophrenia Bulletin
https://www.readbyqxmd.com/read/25744954/an-adaptation-of-motivational-interviewing-increases-quit-attempts-in-smokers-with-serious-mental-illness
#16
Marc L Steinberg, Jill M Williams, Naomi F Stahl, Patricia Dooley Budsock, Nina A Cooperman
INTRODUCTION: Smokers with serious mental illness (SMI) have a high smoking prevalence and a low quit rate. Motivational interviewing (MI) is an empirically supported approach for addressing substance use disorders and may motivate smokers with SMI to quit. METHODS: We randomized smokers (N = 98) with SMI to receive a single 45-minute session of (1) MI with personalized feedback or (2) interactive education. We hypothesized that participants receiving the MI intervention would be more likely to follow-up on a referral for tobacco dependence treatment, to make a quit attempt, and to quit smoking than those receiving the interactive educational intervention...
March 2016: Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco
https://www.readbyqxmd.com/read/27773530/is-it-safe-to-vape-analyzing-online-forums-discussing-e-cigarette-use-during-pregnancy
#17
Britta Wigginton, Coral Gartner, Ingrid J Rowlands
INTRODUCTION: Electronic cigarette (e-cigarette) use, or vaping, is increasing against a backdrop of declining smoking rates. E-cigarettes contain fewer toxicants than cigarettes, but their appearance and mode of use has the potential to satisfy the habitual aspects of smoking. To date, we know little about lay perceptions of the safety of using e-cigarettes in pregnancy. METHODS: We conducted a thematic discourse analysis of 13 online discussion forum threads that discussed e-cigarette use during pregnancy...
January 2017: Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health
https://www.readbyqxmd.com/read/27773711/adolescents-attitudes-towards-e-cigarette-ingredients-safety-addictive-properties-social-norms-and-regulation
#18
Anuradha Gorukanti, Kevin Delucchi, Pamela Ling, Raymond Fisher-Travis, Bonnie Halpern-Felsher
E-cigarette use has dramatically increased. While studies have examined adolescents' attitudes towards smoking, few have extended this research to adolescents' attitudes towards e-cigarettes. The goal of this study was to examine adolescents' attitudes regarding e-cigarette ingredients, safety, addictive properties, social norms, accessibility, price, and regulation; and determine whether attitudes differ by past cigarette/e-cigarette use. Participants were 786 9th and 12th graders from California (63.21% females; mean age=16...
January 2017: Preventive Medicine
https://www.readbyqxmd.com/read/27788063/how-medicaid-and-other-public-policies-affect-use-of-tobacco-cessation-therapy-united-states-2010-2014
#19
Leighton Ku, Erin Brantley, Tyler Bysshe, Erika Steinmetz, Brian K Bruen
INTRODUCTION: State Medicaid programs can cover tobacco cessation therapies for millions of low-income smokers in the United States, but use of this benefit is low and varies widely by state. This article assesses the effects of changes in Medicaid benefit policies, general tobacco policies, smoking norms, and public health programs on the use of cessation therapy among Medicaid smokers. METHODS: We used longitudinal panel analysis, using 2-way fixed effects models, to examine the effects of changes in state policies and characteristics on state-level use of Medicaid tobacco cessation medications from 2010 through 2014...
October 27, 2016: Preventing Chronic Disease
https://www.readbyqxmd.com/read/27816663/impact-of-quitting-smoking-and-smoking-cessation-treatment-on-substance-use-outcomes-an-updated-and-narrative-review
#20
REVIEW
Karma McKelvey, Johannes Thrul, Danielle Ramo
BACKGROUND: Historically, smoking cessation was thought to negatively impact substance use outcomes among smokers who use other substances. We sought to synthesize recent reports on this association. METHODS: Google Scholar, PubMed, and Cinahl were searched for studies published from 2006 to March 29, 2016 that reported impact of smoking cessation treatment or quitting smoking on substance use or substance use disorder treatment outcomes in the general population and among those in substance abuse treatment...
February 2017: Addictive Behaviors
label_collection
label_collection
7273
1
2
2016-11-08 22:32:29
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"